학술논문

The possibility that requiring high-dose olanzapine cannot be explained by pharmacokinetics in the treatment of acute-phase schizophrenia
Document Type
Article
Source
In Psychiatry Research 15 December 2013 210(2):396-401
Subject
Language
ISSN
0165-1781